The appeals court ruled that the abortion pill mifepristone can remain available but with restrictions. However, access remains unchanged until the Supreme Court decides whether to take the case. The case marks a major legal battle since Roe was overturned. While the ruling allows the drug to stay on the market, it turns back changes by the FDA easing access. Any effects of the ruling are delayed as the case will likely return to the Supreme Court. The judges were appointed by Republican presidents and indicated a willingness to restrict the drug during arguments. Overall the ruling was a partial victory for both sides but access remains unsettled as the legal fight continues.
Do you know if that means that the FDA could just backup and do the approval process again and conclude that it does not need to follow the pathway of a dangerous drug? If it aligned with other drugs that way, then legal arguments might be moot?
They might have to depending on the final court opinion. It’s important to know that that’s a long process, it takes about 10 years. I’m not sure about the specifics of what that would look like for a drug getting re-approved.